EDGAR Filing Documents for 0001193125-19-094845

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-19-094845

Filing Date

2019-04-02

Accepted

2019-04-01 20:21:06

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d726062ds3.htm	S-3	537682
2	EX-1.2	d726062dex12.htm	EX-1.2	161368
3	EX-4.4	d726062dex44.htm	EX-4.4	302805
4	EX-4.5	d726062dex45.htm	EX-4.5	303895
5	EX-5.1	d726062dex51.htm	EX-5.1	14104
6	EX-5.2	d726062dex52.htm	EX-5.2	6407
7	EX-23.1	d726062dex231.htm	EX-23.1	1562
8	GRAPHIC	g726062g10y41.jpg	GRAPHIC	40007
9	GRAPHIC	g726062g45h88.jpg	GRAPHIC	103366
	Complete submission text file	0001193125-19-094845.txt		1526249

Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140

Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576

Unum Therapeutics Inc. (Filer) CIK: 0001622229 (see all company filings)